These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21494102)

  • 1. Differential ex vivo and in vivo endotoxin tolerance kinetics following human endotoxemia.
    Kox M; de Kleijn S; Pompe JC; Ramakers BP; Netea MG; van der Hoeven JG; Hoedemaekers CW; Pickkers P
    Crit Care Med; 2011 Aug; 39(8):1866-70. PubMed ID: 21494102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender differences in the innate immune response and vascular reactivity following the administration of endotoxin to human volunteers.
    van Eijk LT; Dorresteijn MJ; Smits P; van der Hoeven JG; Netea MG; Pickkers P
    Crit Care Med; 2007 Jun; 35(6):1464-9. PubMed ID: 17452928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of endotoxin tolerance in humans in vivo.
    Draisma A; Pickkers P; Bouw MP; van der Hoeven JG
    Crit Care Med; 2009 Apr; 37(4):1261-7. PubMed ID: 19242351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of CO2 on cytokine concentrations in endotoxin-stimulated human whole blood.
    Kimura D; Totapally BR; Raszynski A; Ramachandran C; Torbati D
    Crit Care Med; 2008 Oct; 36(10):2823-7. PubMed ID: 18766096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of systemic iNOS inhibition during human endotoxemia on the development of tolerance to different TLR-stimuli.
    Draisma A; Dorresteijn M; Pickkers P; van der Hoeven H
    Innate Immun; 2008 Jun; 14(3):153-9. PubMed ID: 18562574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo lipopolysaccharide exposure of human blood leukocytes induces cross-tolerance to multiple TLR ligands.
    de Vos AF; Pater JM; van den Pangaart PS; de Kruif MD; van 't Veer C; van der Poll T
    J Immunol; 2009 Jul; 183(1):533-42. PubMed ID: 19542464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Of cells and men: ex vivo and in vivo tolerance to lipopolysaccharide.
    Møller K
    Crit Care Med; 2011 Aug; 39(8):1997-8. PubMed ID: 21768803
    [No Abstract]   [Full Text] [Related]  

  • 8. IL-10 and toll-like receptor-4 polymorphisms and the in vivo and ex vivo response to endotoxin.
    Schippers EF; van 't Veer C; van Voorden S; Martina CA; Huizinga TW; le Cessie S; van Dissel JT
    Cytokine; 2005 Mar; 29(5):215-28. PubMed ID: 15760678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-10 and its role in clinical immunoparalysis following pediatric cardiac surgery.
    Allen ML; Hoschtitzky JA; Peters MJ; Elliott M; Goldman A; James I; Klein NJ
    Crit Care Med; 2006 Oct; 34(10):2658-65. PubMed ID: 16932228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How systemic inflammation modulates adenosine metabolism and adenosine receptor expression in humans in vivo.
    Ramakers BP; Wever KE; Kox M; van den Broek PH; Mbuyi F; Rongen G; Masereeuw R; van der Hoeven JG; Smits P; Riksen NP; Pickkers P
    Crit Care Med; 2012 Sep; 40(9):2609-16. PubMed ID: 22732294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalidomide suppressed interleukin-6 but not tumor necrosis factor-alpha in volunteers with experimental endotoxemia.
    Shannon E; Noveck R; Sandoval F; Kamath B; Kearney M
    Transl Res; 2007 Nov; 150(5):275-80. PubMed ID: 17964516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 infusion during human endotoxaemia inhibits in vitro release of the urokinase receptor from peripheral blood mononuclear cells.
    Ostrowski SR; Plomgaard P; Fischer CP; Steensberg AS; Møller K; Høyer-Hansen G; Pedersen BK; Ullum H
    Scand J Immunol; 2005 Feb; 61(2):197-206. PubMed ID: 15683457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage migration inhibitory factor (MIF) in meningococcal septic shock and experimental human endotoxemia.
    Sprong T; Pickkers P; Geurts-Moespot A; van der Ven-Jongekrijg J; Neeleman C; Knaup M; Leroy D; Calandra T; van der Meer JW; Sweep F; van Deuren M
    Shock; 2007 May; 27(5):482-7. PubMed ID: 17438452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No interplay between the pathways mediating coagulation and inflammation in tissue factor-induced disseminated intravascular coagulation in rats.
    Ontachi Y; Asakura H; Takahashi Y; Hayashi T; Arahata M; Kadohira Y; Maekawa M; Omote M; Yoshida T; Yamazaki M; Morishita E; Miyamoto K; Nakao S
    Crit Care Med; 2006 Oct; 34(10):2646-50. PubMed ID: 16932226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF-alpha promoter, Nod2 and toll-like receptor-4 polymorphisms and the in vivo and ex vivo response to endotoxin.
    Schippers EF; van 't Veer C; van Voorden S; Martina CA; le Cessie S; van Dissel JT
    Cytokine; 2004 Apr; 26(1):16-24. PubMed ID: 15016407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ageing is associated with a prolonged fever response in human endotoxemia.
    Krabbe KS; Bruunsgaard H; Hansen CM; Møller K; Fonsmark L; Qvist J; Madsen PL; Kronborg G; Andersen HO; Skinhøj P; Pedersen BK
    Clin Diagn Lab Immunol; 2001 Mar; 8(2):333-8. PubMed ID: 11238217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumor necrosis factor alpha -308 G/A polymorphism does not influence inflammation and coagulation response in human endotoxemia.
    Kovar FM; Marsik C; Cvitko T; Wagner OF; Jilma B; Endler G
    Shock; 2007 Mar; 27(3):238-41. PubMed ID: 17304103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compartmentalization of tolerance to endotoxin.
    Fitting C; Dhawan S; Cavaillon JM
    J Infect Dis; 2004 Apr; 189(7):1295-303. PubMed ID: 15031800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoflurane inhalation after induction of endotoxemia in rats attenuates the systemic cytokine response.
    Flondor M; Hofstetter C; Boost KA; Betz C; Homann M; Zwissler B
    Eur Surg Res; 2008; 40(1):1-6. PubMed ID: 17717418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration of in vivo endotoxin tolerance in horses.
    Holcombe SJ; Jacobs CC; Cook VL; Gandy JC; Hauptman JG; Sordillo LM
    Vet Immunol Immunopathol; 2016 May; 173():10-6. PubMed ID: 27090620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.